Family Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.28M Buy
9,999
+56
+0.6% +$6.55K 0.5% 43
2026
Q1
$1.2M Sell
9,943
-2,198
-18% -$254K 0.53% 41
2025
Q4
$1.28M Buy
12,141
+1,432
+13% +$134K 0.57% 36
2025
Q3
$899K Buy
10,709
+1,808
+20% +$149K 0.43% 45
2025
Q2
$705K Buy
8,901
+5,122
+136% +$407K 0.37% 48
2025
Q1
$339K Buy
3,779
+1,140
+43% +$106K 0.21% 56
2024
Q4
$263K Buy
2,639
+552
+26% +$56.9K 0.16% 58
2024
Q3
$237K Buy
2,087
+24
+1% +$2.85K 0.15% 61
2024
Q2
$255K Buy
2,063
+56
+3% +$7.21K 0.17% 57
2024
Q1
$265K Buy
2,007
+106
+6% +$13.1K 0.18% 58
2023
Q4
$207K Buy
+1,901
New +$197K 0.15% 70

Other funds holding MRK

Family Capital Management's MRK Position: Q2 2026 in Review

Family Capital Management increased its Merck (MRK) stake by 0.56% in Q2 2026, buying an estimated $6.55K and bringing the position to 9,999 shares worth $1.28M. The position accounts for 0.5% of the portfolio, ranked #43.

Family Capital Management first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. 3,841 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Family Capital Management held 9,999 shares of Merck worth $1.28M as of Q2 2026.
  • Family Capital Management bought 56 Merck shares in Q2 2026, an estimated $6.55K.
  • Merck made up 0.5% of Family Capital Management's portfolio in Q2 2026, its #43 holding.
  • Family Capital Management first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
  • 3,841 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Family Capital Management's 13F filing for Q2 2026, filed 31 Jul 2026.